Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

261.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Lancet.
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C.
| Jan 07, 2012
262.

Medical complications associated with earthquakes.

Lancet.
Bartels SA, VanRooyen MJ.
| Feb 25, 2012
263.

Aspirin and colorectal cancer prevention in Lynch syndrome.

Lancet.
Chan AT, Lippman SM.
| Dec 17, 2011
264.

Time for zero deaths from tuberculosis.

Lancet.
Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE.
| Oct 22, 2011
265.

A global scope for global health--including mental health.

Lancet.
Raviola G, Becker AE, Farmer P.
| Nov 05, 2011
266.

Accurate hypertension diagnosis is key in efficient control.

Lancet.
Gaziano TA.
| Oct 01, 2011
267.

Folate and cardiovascular disease: one size does not fit all.

Lancet.
Rimm EB, Stampfer MJ.
| Aug 13, 2011
269.

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Lancet.
Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Skyler JS.
| Jul 30, 2011
270.

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Lancet.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG, Lenhard J.
| Aug 06, 2011
271.

Myxoma, dyspnoea, tinnitus, scoliosis, and alopecia.

Lancet.
Rajab TK, Shekar P, Falk RH.
| Apr 16, 2011
272.

Social accountability in health professionals' training.

Lancet.
Wen LS, Greysen SR, Keszthelyi D, Bracero J, de Roos PD.
| Dec 03, 2011
273.

Transmission dynamics and control of cholera in Haiti: an epidemic model.

Lancet.
Andrews JR, Basu S.
| Apr 09, 2011
275.

EMBRACE, eribulin, and new realities of advanced breast cancer.

Lancet.
Lin NU, Burstein HJ.
| Mar 12, 2011
276.

BLISS! Lupus learns its lessons.

Lancet.
Stone JH.
| Feb 26, 2011
277.

Five complementary interventions to slow cholera: Haiti.

Lancet.
Ivers LC, Farmer P, Almazor CP, Léandre F.
| Dec 18, 2010
278.

A new standard of care in newly diagnosed multiple myeloma.

Lancet.
Richardson PG.
| Dec 18, 2010
279.

Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study.

Lancet.
Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, Murray M, Atwood SS, Mitnick CD.
| Jan 08, 2011
280.

Cholera's western front.

Lancet.
Harris JB, Larocque RC, Charles RC, Mazumder RN, Khan AI, Bardhan PK.
| Dec 11, 2010